{"SPADE_N_15697": {"Sequence Information": {"Peptide Name": "Brevinin-1Yb", "Sequence": "FLPIIAGAAAKVVQKIFCAISKKC", "Sequence Length": 24, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "1. Lithobates yavapaiensis", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.", "Pubmed ID": "19254736", "Reference": "Toxicon. 2009;53:699-705", "Author": "Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/19254736"}, {"Title": "Primary structures of skin antimicrobial peptides indicate a close, but not conspecific, phylogenetic relationship between the leopard frogs Lithobates onca and Lithobates yavapaiensis (Ranidae).", "Pubmed ID": "20044030", "Reference": "Comp Biochem Physiol C Toxicol Pharmacol. 2010;151:313-317", "Author": "Conlon JM, Coquet L, Leprince J, Jouenne T, Vaudry H, King JD", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/20044030"}], "Mass": 2520.15, "PI": 9.7, "Net Charge": 4, "Hydrophobicity": 1.16, "Frequent Amino Acids": "AIK", "Absent Amino Acids": "DEHMNORTUWY", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 16, "Polar Residues": 8, "Positive Residues": 4, "Negative Residues": 0, "SPADE ID": "SPADE_N_15697", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_00138", "Similarity": 1.0, "Sequence": "FLPIIAGAAAKVVQKIFCAISKKC"}, {"SPADE_ID": "SPADE_N_15698", "Similarity": 0.9583333333333334, "Sequence": "FLPIIAGAAAKVVEKIFCAISKKC"}, {"SPADE_ID": "SPADE_UN_00139", "Similarity": 0.9583333333333334, "Sequence": "FLPIIAGAAAKVVEKIFCAISKKC"}], "Hemolytic Activity": "Human erythrocytes:50% Hemolysis=10-16 µM", "Target Organism": "Escherichia coli ATCC 25922(MIC=25µM),Staphylococcus aureus ATCC 25923(MIC=3µM),Candida albicans ATCC 90028(MIC=3-6µM),Human hepatocellular carcinoma HepG2(LC50=11µM)"}}}